- Stent thrombosis or Restenosis: the dilemma of an equivocal STEMI patient
- Transaxillary transcatheter aortic valve implantation (TAVI) as valve-in-valve procedure due to degeneration of an aortic bioprosthesis
- A chronic total occlusion (CTO) of ostial LAD in a young patient
- Percutaneous LAA closure in an elderly woman with contra-indication to oral anticoagulant therapy
- Antithrombotic strategy during PCI: challenging situations
- Multivessel disease and cardiac arrest
- A Large Atrial Septal Defect in a 59 year old male patient
Abu Bakar – October 29, 2014
“Good result .patient with IABP I normally user femoral approach .normally put IABP on left side n...”
Abu Bakar – October 29, 2014
“I don't have BVS on my self,so DES.In Pakistan no OCT.though it's not as informative as OCT/IVUS,...”
imran abid – October 28, 2014
“Its a great thing to have in cath lab if it is the case. imran abid PIC lahore”
tamim kanaan – October 26, 2014
“Definitely BVS is an attractive option in order to avoid adding a new metal layer, but I am very...”
mazen sudqi abuhusein – October 25, 2014
“I think that DES is the best ,and I will cover the whole lesion”
- Learning the techniques of renal denervation
Learning the techniques of renal denervation
Renal denervation has been shown to safely reduce sympathetic nerve activity and blood pressure in patients with resistant hypertension. During this “Learning…” session, you will receive a critical overview of the key information on the current catheter-based renal sympathetic denervation devices.
Christian Ukena, who is facilitating the session with Felix Mahfoud, Atul Pathak, and Thomas Zeller, said: “Hypertension is the leading cause of death worldwide. Despite the availability of safe and effective antihypertensive drugs, control rates of patients with hypertension are low. At present, numerous interventional devices with different properties for managing resistant hypertension are now available or are being investigated in trials. Therefore, an overview on the current devices concerning their interventional features and clinical data is needed.”
He added that several questions about renal denervation remained, including understanding which procedural details during the ablation are important, what the parameters of treatment success are, what the advantages and disadvantages of the different devices are, and what the differences are concerning the safety and efficacy of the different devices.
This “Learning…” session will provide information on these questions by giving you a critical overview of the catheter-based renal denervation devices available. There will also be a “Live ina- box” case presentation; “Live in-a-box” presentations are recorded LIVE demonstrations and their aim is to emphasise the key educational messages of a specific topic (so in this session, renal denervation).
C.Ukena said you should attend this session to learn how to perform a safe and effective procedure with the different devices, learn the tips of tricks of negotiating difficult anatomy, understand the different properties of CE marked devices, and be informed about upcoming future devices.
The media driver for the session is Leonardo Misuraca.